Deals Of The Week: Keeping Score – Valeant Wants Actavis, Which Covets Warner Chilcott …

 
• By Jessica Merrill, Lisa LaMotta, Tamra Sami, Sten Stovall, and Chris Morrison

Meanwhile, companies like Mylan and Novartis also reportedly have joined the Actavis chase. In addition, there’s been deal-making news from Elan and Theravance, Merck-Serono and Quintiles, and AbbVie and Alvine.

More from Archive

More from Pink Sheet